Skip to main content

Table 4 Antimicrobial susceptibility of Gram-positive isolates

From: Epidemiology of patients with central nervous system infections, mainly neurosurgical patients: a retrospective study from 2012 to 2019 in a teaching hospital in China

 

CoNS (N = 37)

Streptococcus pneumoniae (N = 5)

Enterococcus faecium (N = 5)

 

n

S

I

R

n

S

I

R

n

S

I

R

Penicillin

37

1 (2.7%)

 

36 (97.3%)

5

2 (40%)

 

3 (60%)

5

  

5 (100%)

Oxacillin

37

7 (18.9%)

 

30 (81.1%)

   

   

Ampicillin

   

   

5

  

5 (100%)

Amoxicillin-Clavulanate

34

7 (20.6%)

 

27 (79.4%)

   

   

Cefazolin

28

4 (14.3%)

 

24 (85.7%)

   

   

Ciprofloxacin

16

5 (31.3%)

 

11 (68.8%)

   

5

  

5 (100%)

Levofloxacin

20

8 (40%)

5 (25%)

7 (35%)

5

5 (100%)

  

   

Moxifloxacin

6

3 (50%)

1(16.7%)

2(33.3%)

5

5 (100%)

  

   

Tetracycline

36

27 (75%)

 

9 (25%)

5

 

1 (20%)

4 (80%)

5

3 (60%)

 

2 (40%)

Erythrocin

37

4 (10.8%)

 

33 (89.2%)

5

 

1 (20%)

4 (80%)

   

Clindamycin

37

14 (37.8%)

7 (18.9%)

16 (43.2%)

3

  

3 (100%)

   

Chloramphenicol

   

5

4 (80%)

 

1 (20%)

5

3 (60%)

2 (40%)

 

Rifampicin

35

28 (80%)

 

7 (20%)

2

2 (100%)

  

5

1 (20%)

 

4 (80%)

Compound Sulfamethoxazole

37

9 (24.3%)

 

28 (75.7%)

5

2 (40%)

1 (20%)

2 (40%)

   

Gentamicin

37

21 (56.8%)

1 (2.7%)

15 (40.5%)

   

5

1 (20%)

 

4 (80%)

Vancomycin

37

37 (100%)

  

5

5 (100%)

  

5

5 (100%)

  

Teicoplanin

37

37 (100%)

  

5

5 (100%)

  

5

5 (100%)

  

Linezolid

37

37 (100%)

  

2

2 (100%)

  

5

5 (100%)

  
  1. S sensitive, I intermediary, R resistant, (–) not done